Infervision

Infervision

Private
Beijing, BeijingHealthcare & Life Scienceshttps://www.infervision.com

Last Round

Series D

Aug 13, 2021

Total Funding Raised

$213M

Company Overview

Infervision is a healthcare technology company that develops artificial intelligence-assisted medical imaging diagnosis equipment to enhance diagnostic accuracy, improve outcomes, reduce costs, and increase efficiency for doctors and medical institutions.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Computer Vision

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting

AI Layer

Application

Keywords

medical imaging AIradiology AImedical image analysisAI diagnosticscomputer-aided diagnosisCADxFDA cleared AIdeep learning softwareCE marked AIstroke detectionlung cancer screeningcomputer visionPACS integrationclinical decision supportsurgical planning software3D reconstruction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Infervision Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Infervision Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DAug 13, 2021
Series CDec 7, 2018
Series B ExtensionMar 19, 2018
Series BSep 20, 2017
Series AJan 1, 2017

Infervision Investors

Notable investors and investment history

InvestorRounds
CDH InvestmentsSeries D, Series C
Taihe CapitalSeries C
GaingelsSeries B Extension, Series B
Goldman Sachs Asset Management Private EquitySeries D
Z-Park FundSeries D
Genesis CapitalSeries B Extension, Series B
Sequoia CapitalSeries D, Series A, Series B, Series C

Infervision Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Infervision Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Infervision's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Employee Range73
Year Founded2016
Last FundingAug 13, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.